ENVISTA HOLDINGS CORPORATION Envista Holdings Corporation Stock
Equities
NVST
US29415F1049
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.51 USD | +2.45% |
|
+2.81% | -14.71% |
| 12:51pm | Morgan Stanley Downgrades Envista Holdings to Equalweight From Overweight, Cuts Price Target to $21 From $33 | MT |
| Apr. 15 | Envista Holdings Names Paul Keel as CEO | MT |
Financials (USD)
| Sales 2024 * | 2.6B | Sales 2025 * | 2.7B | Capitalization | 3.44B |
|---|---|---|---|---|---|
| Net income 2024 * | 200M | Net income 2025 * | 220M | EV / Sales 2024 * | 1.52 x |
| Net Debt 2024 * | 499M | Net Debt 2025 * | 238M | EV / Sales 2025 * | 1.36 x |
| P/E ratio 2024 * |
17.9
x | P/E ratio 2025 * |
16.5
x | Employees | 12,800 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.54% |
More Fundamentals
* Assessed data
More news
Latest transcript on Envista Holdings Corporation
More recommendations
More news
| 1 day | -1.28% | ||
| 1 week | +1.37% | ||
| Current month | -6.36% | ||
| 1 month | -4.48% | ||
| 3 months | -17.34% | ||
| 6 months | -18.75% | ||
| Current year | -16.79% |
1 week
19.84
20.57
1 month
18.9621.62
Current year
18.9625.64
1 year
18.9638.68
3 years
18.9652.03
5 years
10.0852.03
10 years
10.0852.03
| Managers | Title | Age | Since |
|---|---|---|---|
Amir Aghdaei
CEO | Chief Executive Officer | 66 | 19-04-30 |
Stephen Keller
DFI | Director of Finance/CFO | 49 | 18-12-31 |
Andrew Chen
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 19-08-31 | |
Daniel Raskas
BRD | Director/Board Member | 57 | 18-12-31 |
Vivek Jain
BRD | Director/Board Member | 52 | 20-04-06 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.75% | 8 M€ | +2.44% | ||
| 0.69% | 2 M€ | +6.77% | ||
| 0.34% | 509 M€ | -.--% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 20.51 | +2.45% | 1 083 938 |
| 24-04-25 | 20.02 | -1.28% | 1,193,865 |
| 24-04-24 | 20.28 | +0.30% | 1,173,568 |
| 24-04-23 | 20.22 | +0.55% | 1,329,110 |
| 24-04-22 | 20.11 | +0.75% | 1,590,770 |
Delayed Quote Nyse, April 25, 2024 at 04:00 pm EDT
More quotes
Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.
Calendar
2024-05-01
- Q1 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
20.02
USD
Average target price
23.18
USD
Spread / Average Target
+15.79%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -16.79% | 3.44B | |
| -2.92% | 185B | |
| -3.80% | 105B | |
| -5.48% | 66.59B | |
| +11.22% | 54.66B | |
| +16.74% | 47.78B | |
| +4.06% | 41.26B | |
| +4.56% | 26.95B | |
| +1.64% | 26.37B | |
| +12.96% | 24.8B |
- Stock Market
- Equities
- NVST Stock
